GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Dec. 31, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in goodwill for the years ended December 31, 2012 and 2011 were as follows:



	2012			2011

Balance at beginning of year	$	5,795,765		$	5,101,938
Goodwill acquired during the year	28,144			701,087
Goodwill impairment and write-off associated with sale of business during the year	(85,173		)	—
Reclassification to non-current assets held for sale	(218,795		)	—
Increase (decrease) related to foreign currency translation	15,907			(7,260		)

Balance at end of year	$	5,535,848		$	5,795,765

Approximately 90% of the Company’s goodwill as of December 31, 2012 and 2011 was associated with its DIS business.

For the year ended December 31, 2012, goodwill acquired was principally associated with the acquisition of S.E.D.. For the year ended December 31, 2011, goodwill acquired was principally associated with the Athena and Celera acquisitions. See Note 5 for further details.

For the year ended December 31, 2012, goodwill impairment was associated with the agreement to sell HemoCue and the write-off of goodwill was associated with the sale of OralDNA. For further details regarding goodwill included in non-current assets held for sale, see Note 18.

Intangible assets at December 31, 2012 and 2011 consisted of the following:



	Weighted Average Amortization Period (Years)	December 31, 2012							December 31, 2011
		Cost		Accumulated Amortization			Net		Cost		Accumulated Amortization			Net
Amortizing intangible assets:
Customer-related intangibles	19	$	566,701	$	(173,516	)	$	393,185	$	630,671	$	(193,131	)	$	437,540
Non-compete agreements	4	38,551		(17,123		)	21,428		45,798		(14,633		)	31,165
Technology	14	131,040		(25,144		)	105,896		165,113		(27,929		)	137,184
Other	8	141,818		(37,634		)	104,184		146,613		(23,552		)	123,061

Total	16	878,110		(253,417		)	624,693		988,195		(259,245		)	728,950

Intangible assets not subject to amortization:
Tradenames		246,200		—			246,200		300,648		—			300,648
In-process research and development		120		—			120		5,250		—			5,250
Other		1,159		—			1,159		764		—			764

Total intangible assets		$	1,125,589	$	(253,417	)	$	872,172	$	1,294,857	$	(259,245	)	$	1,035,612

Amortization expense related to intangible assets was $75 million, $61 million and $33 million for the years ended December 31, 2012, 2011 and 2010, respectively.

The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of December 31, 2012 is as follows:



Year Ending December 31,
2013	$	72,979
2014	70,817
2015	59,552
2016	52,842
2017	49,088
Thereafter	319,415

Total	$	624,693

In December 2012, $219 million of goodwill and $111 million of intangible assets, net were reclassified to non-current assets held for sale in the Consolidated Balance Sheet. For further discussion see Note 18.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details